Transcatheter Aortic Valve Replacement (TAVR / TAVI) TAVR / TAVI

A minimally invasive, catheter-based treatment that replaces a severely narrowed aortic valve without open-heart surgery.

Call for Consultation

Procedure Type Minimally invasive

Hospital Stay Usually 24–48 hours

Recovery Generally faster

Suitability After cardiac evaluation

Treatment Overview

TAVR / TAVI Treatment

TAVR (Transcatheter Aortic Valve Replacement), also known as TAVI, is an advanced treatment for severe aortic valve stenosis, in which the aortic valve becomes thickened and narrowed, restricting blood flow from the heart to the rest of the body. It offers a proven, minimally invasive alternative to open-heart aortic valve surgery, particularly for elderly and high-risk patients.

Patient suitability is determined after detailed clinical examination, echocardiography and evaluation of the defect’s size, position and anatomy.

Conditions Treated

Conditions treated with TAVR / TAVI

Aortic Stenosis Severe Aortic Valve Stenosis

Age-related thickening and narrowing of the aortic valve that restricts blood flow and forces the heart to work harder.

Bicuspid Valve Bicuspid Aortic Valve Disease

A congenital valve variation with two leaflets instead of three, which can narrow prematurely and may require specialised TAVR planning.

Failed Surgical Valve Degenerated Bioprosthetic Aortic Valve

A previously implanted surgical valve that has worn out over time, treatable with valve-in-valve TAVR.

High Surgical Risk High-Risk for Open Surgery

Patients whose age or co-existing illnesses make conventional open-heart valve surgery unsafe, making TAVR the preferred option.

Procedure

How the TAVR / TAVI procedure is performed

In TAVR, a new, collapsible artificial valve is delivered on a catheter, usually through the femoral artery in the groin, and expanded precisely inside the diseased native aortic valve. The new valve immediately takes over the job of regulating blood flow, without the need to open the chest or stop the heart, as required in conventional surgical valve replacement.

The procedure is performed in a specialised cardiac catheterisation laboratory. Continuous imaging allows accurate positioning of the device and assessment of the result before completion.

Key Benefits

Benefits of TAVR / TAVI

No open-heart surgery, chest incision or heart-lung machine required in most cases
Shorter hospital stay compared to surgical aortic valve replacement
Faster relief from breathlessness, chest discomfort and fatigue
Lower procedural risk for elderly and high-risk patients
Excellent long-term valve performance with newer generation devices
Suitable for complex cases including bicuspid valve and valve-in-valve TAVR

Recovery

Recovery after the procedure

Recovery after TAVR is generally quick, with most patients mobile within 24 hours and discharged within two to four days. Regular follow-up with echocardiography is advised to monitor valve function, along with guideline-directed medication for long-term heart health.

Medication instructions and follow-up schedules should be followed carefully. Contact the treating doctor immediately in case of unusual pain, bleeding, swelling, fever or breathing difficulty.

Treatment Journey

What happens during the procedure?

Each treatment is planned according to the patient’s heart anatomy, medical condition and clinical requirements.

Detailed Imaging Work-up

Echocardiography and CT angiography are used to measure the valve annulus and plan the ideal valve size and access route.

Vascular Access

A small puncture is made, usually in the femoral artery, under local anaesthesia or light sedation.

Valve Delivery

The collapsed replacement valve is guided on a catheter to the site of the diseased aortic valve under live imaging.

Valve Deployment

The new valve is expanded within the native valve, immediately restoring normal blood flow through the heart.

Confirmation and Recovery

Imaging confirms correct valve position and function before the catheter is withdrawn and the access site is closed.

Your Heart Specialist

Dr. Prashant Dwivedi

Interventional and Structural Heart Cardiologist

Dr. Prashant Dwivedi is Director & Head of the TAVR and Structural Heart Programme, trained at Mount Sinai Hospital, New York, with experience of over a thousand TAVR procedures, including complex cases such as bicuspid aortic valve, valve-in-valve TAVR and TAVR-in-TAVR, for patients across Jaipur and Rajasthan.

Structural Heart Expertise Advanced Catheter Procedures Patient-Centred Care

Frequently Asked Questions

Questions about TAVR / TAVI treatment

General information to help patients understand the procedure. Individual advice may differ according to medical condition.

No. TAVR is a minimally invasive, catheter-based procedure performed through a small puncture, usually in the groin, without opening the chest or stopping the heart.

The procedure typically takes one to two hours, and most patients are discharged within two to four days, much sooner than after open-heart valve surgery.

Yes, in appropriately selected patients. Dr. Prashant Dwivedi has specific experience performing TAVR in bicuspid aortic valve anatomy, which requires careful pre-procedural imaging and planning.

A previously implanted surgical aortic valve that degenerates over time can often be treated with valve-in-valve TAVR, avoiding the need for repeat open-heart surgery.

Get expert guidance for your heart condition

Schedule an appointment with Dr. Prashant Dwivedi for accurate evaluation, personalised advice and advanced cardiac treatment planning.